KROS · Forms 3, 4, 5
Insider trades at Keros Therapeutics, Inc.
4 insiders sold $101K and 1 insider bought $10K of Keros Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Keros Therapeutics, Inc. (KROS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Annita Tanini | Corp. Controller & VP, Finance | Sell | 1,224 | $10.29 | $13K | Form 4 | |
| Lorena Raquel Lerner | Chief Scientific Officer | Sell | 3,568 | $10.29 | $37K | Form 4 | |
| Esther Cho | Chief Legal Officer | Sell | 4,485 | $10.29 | $46K | Form 4 | |
| Charles W. Newton | Director | Sell (10b5-1 plan) | 551 | $10.30 | $6K | Form 4 | |
| Jean Jacques Bienaime | Director | Buy | 1,000 | $10.27 | $10K | Form 4 | |
| Annita Tanini | Corp. Controller & VP, Finance | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.